Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)

Condition:   Primary Central Nervous System Lymphoma Intervention:   Drug: Orelabrutinib,Rituximab and Methotrexate Sponsor:   Affiliated Hospital to Academy of Military Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials